絞り込み

18381

広告

「叡王戦」異例の第9局で豊島竜王勝利「二冠」に返り咲き

将棋の八大タイトルの1つ「叡王戦」の七番勝負は、2回の引き分けがあったことから「第9局」までもつれ込む異例の展開となった結果、挑戦者の豊島将之竜王(30)がタイ...

  1. [企業] RocheがInflazome...
  2. 20世紀まで残った決闘 中心地だったフラ...
  3. 森と湖が広がる北の原野に環境破壊の恐れ、...
  4. 検証プラス・新型コロナ:遅い政策、消えた...

ニュース一覧

Autophagic- and Lysosomal-Related Biomarkers for Parkinson's Disease: Lights and Shadows.

著者 Xicoy H , Peñuelas N , Vila M , Laguna A
Cells.2019 Oct 25 ; 8(11):.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (43view , 0users)

Full Text Sources

Miscellaneous

Parkinson's disease (PD) is a neurodegenerative disorder that currently affects 1% of the population over the age of 60 years, for which no disease-modifying treatments exist. This lack of effective treatments is related to the advanced stage of neurodegeneration existing at the time of diagnosis. Thus, the identification of early stage biomarkers is crucial. Biomarker discovery is often guided by the underlying molecular mechanisms leading to the pathology. One of the central pathways deregulated during PD, supported both by genetic and functional studies, is the autophagy-lysosomal pathway. Hence, this review presents different studies on the expression and activity of autophagic and lysosomal proteins, and their functional consequences, performed in peripheral human biospecimens. Although most biomarkers are inconsistent between studies, some of them, namely HSC70 levels in sporadic PD patients, and cathepsin D levels and glucocerebrosidase activity in PD patients carrying mutations, seem to be consistent. Hence, evidence exists that the impairment of the autophagy-lysosomal pathway underlying PD pathophysiology can be detected in peripheral biosamples and further tested as potential biomarkers. However, longitudinal, stratified, and standardized analyses are needed to confirm their clinical validity and utility.
PMID: 31731485 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード